8th Feb 2022 14:41
Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Shareholders vote to approve Clinigen's acquisition by funds managed by Triton Investment Management Ltd. At both the general and court meetings held on Tuesday, the takeover was approved by the same percentages of 91% to 9% among shares voted. The private equity firm offered 925 pence per share in cash, valuing Clinigen at GBP1.3 billion. The deal remain subject to antitrust and foreign investment approvals.
Current stock price: 919.50p, up 1.0% on Tuesday
12-month change: up 17%
By Tom Waite; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.